Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125926352 | 12592635 | 2 | F | 201606 | 20160728 | 20160726 | 20160803 | EXP | US-GLAXOSMITHKLINE-US2016106815 | GLAXOSMITHKLINE | 59.61 | YR | F | Y | 0.00000 | 20160803 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125926352 | 12592635 | 1 | PS | TANZEUM | ALBIGLUTIDE | 1 | Subcutaneous | 30 MG, WE | GAOH19ADA | 125431 | 30 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | /wk | |||||
125926352 | 12592635 | 2 | SS | COUMADIN | WARFARIN SODIUM | 1 | U | UNKNOWN | 0 | ||||||||||
125926352 | 12592635 | 3 | SS | LOVENOX | ENOXAPARIN SODIUM | 1 | U | UNKNOWN | 0 | SOLUTION FOR INJECTION | |||||||||
125926352 | 12592635 | 4 | C | DEXILANT | DEXLANSOPRAZOLE | 1 | U | 0 | |||||||||||
125926352 | 12592635 | 5 | C | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | U | 0 | |||||||||||
125926352 | 12592635 | 6 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
125926352 | 12592635 | 7 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | U | 0 | |||||||||||
125926352 | 12592635 | 8 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
125926352 | 12592635 | 9 | C | FOLIC ACID. | FOLIC ACID | 1 | U | N | 0 | ||||||||||
125926352 | 12592635 | 10 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125926352 | 12592635 | 1 | Diabetes mellitus |
125926352 | 12592635 | 2 | Product used for unknown indication |
125926352 | 12592635 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125926352 | 12592635 | OT |
125926352 | 12592635 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125926352 | 12592635 | Altered state of consciousness | |
125926352 | 12592635 | Apparent death | |
125926352 | 12592635 | Blood viscosity increased | |
125926352 | 12592635 | Drug ineffective | |
125926352 | 12592635 | Erythema | |
125926352 | 12592635 | Factor VIII deficiency | |
125926352 | 12592635 | Headache | |
125926352 | 12592635 | Migraine | |
125926352 | 12592635 | Peripheral swelling | |
125926352 | 12592635 | Pulmonary thrombosis | |
125926352 | 12592635 | Surgery | |
125926352 | 12592635 | Thrombosis | |
125926352 | 12592635 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125926352 | 12592635 | 1 | 2015 | 0 |